233 related articles for article (PubMed ID: 35107878)
1. Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours.
Groelly FJ; Porru M; Zimmer J; Benainous H; De Visser Y; Kosova AA; Di Vito S; Serra V; Ryan A; Leonetti C; Bruna A; Biroccio A; Tarsounas M
EMBO Mol Med; 2022 Mar; 14(3):e14501. PubMed ID: 35107878
[TBL] [Abstract][Full Text] [Related]
2. Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds.
Zimmer J; Tacconi EMC; Folio C; Badie S; Porru M; Klare K; Tumiati M; Markkanen E; Halder S; Ryan A; Jackson SP; Ramadan K; Kuznetsov SG; Biroccio A; Sale JE; Tarsounas M
Mol Cell; 2016 Feb; 61(3):449-460. PubMed ID: 26748828
[TBL] [Abstract][Full Text] [Related]
3. The G-quadruplex DNA stabilizing drug pyridostatin promotes DNA damage and downregulates transcription of Brca1 in neurons.
Moruno-Manchon JF; Koellhoffer EC; Gopakumar J; Hambarde S; Kim N; McCullough LD; Tsvetkov AS
Aging (Albany NY); 2017 Sep; 9(9):1957-1970. PubMed ID: 28904242
[TBL] [Abstract][Full Text] [Related]
4. G-quadruplex DNA as a molecular target for induced synthetic lethality in cancer cells.
McLuckie KI; Di Antonio M; Zecchini H; Xian J; Caldas C; Krippendorff BF; Tannahill D; Lowe C; Balasubramanian S
J Am Chem Soc; 2013 Jul; 135(26):9640-3. PubMed ID: 23782415
[TBL] [Abstract][Full Text] [Related]
5. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.
Xu H; Di Antonio M; McKinney S; Mathew V; Ho B; O'Neil NJ; Santos ND; Silvester J; Wei V; Garcia J; Kabeer F; Lai D; Soriano P; Banáth J; Chiu DS; Yap D; Le DD; Ye FB; Zhang A; Thu K; Soong J; Lin SC; Tsai AH; Osako T; Algara T; Saunders DN; Wong J; Xian J; Bally MB; Brenton JD; Brown GW; Shah SP; Cescon D; Mak TW; Caldas C; Stirling PC; Hieter P; Balasubramanian S; Aparicio S
Nat Commun; 2017 Feb; 8():14432. PubMed ID: 28211448
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of neurons, astrocytes, and microglia to G-quadruplex stabilization.
Tabor N; Ngwa C; Mitteaux J; Meyer MD; Moruno-Manchon JF; Zhu L; Liu F; Monchaud D; McCullough LD; Tsvetkov AS
Aging (Albany NY); 2021 Jun; 13(12):15917-15941. PubMed ID: 34139671
[TBL] [Abstract][Full Text] [Related]
7. Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.
Tacconi EM; Badie S; De Gregoriis G; Reisländer T; Lai X; Porru M; Folio C; Moore J; Kopp A; Baguña Torres J; Sneddon D; Green M; Dedic S; Lee JW; Batra AS; Rueda OM; Bruna A; Leonetti C; Caldas C; Cornelissen B; Brino L; Ryan A; Biroccio A; Tarsounas M
EMBO Mol Med; 2019 Jul; 11(7):e9982. PubMed ID: 31273933
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting and patient selection for cancers with homologous recombination defects.
Talens F; Jalving M; Gietema JA; Van Vugt MA
Expert Opin Drug Discov; 2017 Jun; 12(6):565-581. PubMed ID: 28425306
[TBL] [Abstract][Full Text] [Related]
10. EXO1 protects BRCA1-deficient cells against toxic DNA lesions.
van de Kooij B; Schreuder A; Pavani R; Garzero V; Uruci S; Wendel TJ; van Hoeck A; San Martin Alonso M; Everts M; Koerse D; Callen E; Boom J; Mei H; Cuppen E; Luijsterburg MS; van Vugt MATM; Nussenzweig A; van Attikum H; Noordermeer SM
Mol Cell; 2024 Feb; 84(4):659-674.e7. PubMed ID: 38266640
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
12. ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.
Yazinski SA; Comaills V; Buisson R; Genois MM; Nguyen HD; Ho CK; Todorova Kwan T; Morris R; Lauffer S; Nussenzweig A; Ramaswamy S; Benes CH; Haber DA; Maheswaran S; Birrer MJ; Zou L
Genes Dev; 2017 Feb; 31(3):318-332. PubMed ID: 28242626
[TBL] [Abstract][Full Text] [Related]
13. The
Simoneau A; Xiong R; Zou L
Genes Dev; 2021 Sep; 35(17-18):1271-1289. PubMed ID: 34385259
[TBL] [Abstract][Full Text] [Related]
14. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
[TBL] [Abstract][Full Text] [Related]
15. Pirh2-dependent DNA damage in neurons induced by the G-quadruplex ligand pyridostatin.
Escarcega RD; Patil AA; Moruno-Manchon JF; Urayama A; Marrelli SP; Kim N; Monchaud D; McCullough LD; Tsvetkov AS
J Biol Chem; 2023 Oct; 299(10):105157. PubMed ID: 37579947
[TBL] [Abstract][Full Text] [Related]
16. EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation.
Rondinelli B; Gogola E; Yücel H; Duarte AA; van de Ven M; van der Sluijs R; Konstantinopoulos PA; Jonkers J; Ceccaldi R; Rottenberg S; D'Andrea AD
Nat Cell Biol; 2017 Nov; 19(11):1371-1378. PubMed ID: 29035360
[TBL] [Abstract][Full Text] [Related]
17. DNA repair protein RAD52 is required for protecting G-quadruplexes in mammalian cells.
Liu S; Wang Z; Shah SB; Chang CY; Ai M; Nguyen T; Xiang R; Wu X
J Biol Chem; 2023 Jan; 299(1):102770. PubMed ID: 36470428
[TBL] [Abstract][Full Text] [Related]
18. ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2
Liu L; Cai S; Han C; Banerjee A; Wu D; Cui T; Xie G; Zhang J; Zhang X; McLaughlin E; Yin M; Backes FJ; Chakravarti A; Zheng Y; Wang QE
Mol Cancer Ther; 2020 Jan; 19(1):199-210. PubMed ID: 31534014
[TBL] [Abstract][Full Text] [Related]
19. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks.
Nagaraju G; Scully R
DNA Repair (Amst); 2007 Jul; 6(7):1018-31. PubMed ID: 17379580
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.
Fridlich R; Annamalai D; Roy R; Bernheim G; Powell SN
DNA Repair (Amst); 2015 Jun; 30():11-20. PubMed ID: 25836596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
